Windrose Consulting Group at J&J Innovative Medicine Vendor Expo | May 2026
Global leaders in value, pricing, and market access strategy
P&MA insights across all stages of the product lifecycle, from early pipeline agents to launch preparation to loss of exclusivity
Meet the Windrose J&J Leadership team
-
![Colin Nash]()
Colin Nash
PARTNER
Colin has over 15 years of experience in the Life Sciences industry, holding a number of senior roles focused on global pricing, market access, and commercialization strategy.
-
![Anais Frappe]()
Anais Frappe
PARTNER
Anais is a Partner at Windrose and will be in a Panel at EPA. She has over fourteen years of working experience in the Life Sciences industry globally, spanning across market access & pricing, sales & commercial, private equity, medical affairs, regulatory, and org. design. -
![Adam Foster]()
Adam Foster
MANAGING PARTNER
Adam advises healthcare clients on a broad range of strategic growth initiatives, including global pricing and market access, new product and portfolio commercial strategies, in-licensing / asset acquisition valuations and product life-cycle planning.
-
![Mark Kohler]()
Mark Kohler
SENIOR PRINCIPAL
Mark has over 12 years of consulting experience in the healthcare industry. He has managed projects for pharmaceutical companies covering a variety of global pricing and market access initiatives across a number of disease states.
-
![Maja Warrum]()
Maja Warrum
SENIOR ENGAGEMENT MANAGER
Maja has over 9 years of consulting experience in the pharmaceutical industry. She has a strong background in developing commercialization, pricing, and reimbursement strategies for products in a range of diseases, with extensive experience in hematologic oncology, inflammatory conditions, and rare diseases.
